|

Asciminib single agent Clinical Trials

1 actively recruiting trial across 1 location

Also known as: ABL001

Pipeline

Phase 4: 1

Top Sponsors

  • Novartis Pharmaceuticals1

Indications

  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive1
  • Chronic Myelogenous Leukemia1
  • Cancer1

Ann Arbor, Michigan1 trial

Asciminib Roll-over Study

Michigan Med University of Michigan

Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.